Published February 10, 2011 | Version v1
Journal article

Differential expression of the klf6 tumor suppressor gene upon cell damaging treatments in cancer cells

  • 1. Centro de Investigaciones en Bioquimica Clinica e Inmunologia (CIBICI-CONICET), Departamento de Bioquimica Clinica, Facultad de Ciencias Quimicas, Universidad Nacional de Cordoba, Haya de la Torre y Medina Allende, Ciudad Universitaria, 5000 Cordoba (Argentina)

Description

The mammalian Krueppel-like factor 6 (KLF6) is involved in critical roles such as growth-related signal transduction, cell proliferation and differentiation, development, apoptosis and angiogenesis. Also, KLF6 appears to be an emerging key factor during cancer development and progression. Its expression is thoroughly regulated by several cell-damaging stimuli. DNA damaging agents at lethal concentrations induce a p53-independent down-regulation of the klf6 gene. To investigate the impact of external stimuli on human klf6 gene expression, its mRNA level was analyzed using a cancer cell line profiling array system, consisting in an assortment of immobilized cDNAs from multiple cell lines treated with several cell-damaging agents at growth inhibitory concentrations (IC50). Cell-damaging agents affected the klf6 expression in 62% of the cDNA samples, though the expression pattern was not dependent on the cell origin type. Interestingly, significant differences (p < 0.0001) in KLF6 mRNA levels were observed depending on the cellular p53 status upon cell damage. KLF6 expression was significantly increased in 63% of p53-deficient cells (122/195). Conversely, KLF6 mRNA level decreased nearly 4 fold in more than 70% of p53+/+ cells. In addition, klf6 gene promoter activity was down-regulated by DNA damaging agents in cells expressing the functional p53 protein whereas it was moderately increased in the absence of functional p53. Consistent results were obtained for the endogenous KLF6 protein level. Results indicate that human klf6 gene expression is responsive to external cell damage mediated by IC50 concentrations of physical and chemical stimuli in a p53-dependent manner. Most of these agents are frequently used in cancer therapy. Induction of klf6 expression in the absence of functional p53 directly correlates with cell death triggered by these compounds, whereas it is down-regulated in p53+/+ cells. Hence, klf6 expression level could represent a valuable marker for the efficiency of cell death upon cancer treatment.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.mrfmmm.2010.12.002

Additional details

Identifiers

DOI
10.1016/j.mrfmmm.2010.12.002;
PII
S0027-5107(10)00309-X;

Publishing Information

Journal Title
Mutation Research
Journal Volume
707
Journal Issue
1-2
Journal Page Range
p. 15-23
ISSN
0027-5107

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
44100037
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
ANGIOGENESIS; APOPTOSIS; CELL PROLIFERATION; CHEMOTHERAPY; CONCENTRATION RATIO; DNA; GENES; MESSENGER-RNA; NEOPLASMS; PROMOTERS; PROTEINS
Descriptors DEC
DIMENSIONLESS NUMBERS; DISEASES; MEDICINE; NUCLEIC ACIDS; ORGANIC COMPOUNDS; RNA; THERAPY

Optional Information

Copyright
Copyright (c) 2011 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.